Showing results (171-180 of 300) with videos related to
Sort By:
Pageof 30
Blood|September 1, 1994
Clinical spectrum of clonal proliferations of T-large granular lymphocytes: a T-cell clonopathy of undetermined significance?M V Dhodapkar, C Y Li, J A Lust, et al.Inflammatory Bowel Diseases|May 25, 1999
Concurrent inflammatory bowel disease and myelodysplastic syndromesG C Harewood, E V Loftus, A Tefferi, et al.Leukemia Research|April 20, 2006
The third International Congress on Myeloproliferative and Myelodysplastic SyndromesR T Silver, J M Bennett, J M Goldman, et al.Blood|July 1, 1989
Isolation of a heparin-like anticoagulant from the plasma of a patient with metastatic bladder carcinomaA Tefferi, B A Owen, W L Nichols, et al.Seminars in Thrombosis and Hemostasis|January 1, 1997
Anagrelide as a new platelet-lowering agent in essential thrombocythemia: mechanism of actin, efficacy, toxicity, current indicationsA Tefferi, M N Silverstein, R M Petitt, et al.Acta Dermato-Venereologica|January 1, 1989
Transient acantholytic dermatosis associated with lymphomatous angioimmunoblastic lymphadenopathyB D Zelickson, A Tefferi, M A Gertz, et al.Mayo Clinic Proceedings|February 1, 1992
Cytogenetic and molecular detection of residual leukemic cells after allogeneic bone marrow transplantation in chronic granulocytic leukemiaD L Graham, A Tefferi, L Letendre, et al.American Journal of Clinical Oncology|October 1, 1995
Continuous infusion etoposide/carboplatin for treatment of refractory acute leukemiaL Letendre, P Noel, A Tefferi, et al.Leukemia|May 17, 2003
In vitro antiproliferative activity of the farnesyltransferase inhibitor R115777 in hematopoietic progenitors from patients with myelofibrosis with myeloid metaplasiaR A Mesa, A Tefferi, L A Gray, et al.Leukemia|April 23, 2010
IDH1 and IDH2 mutation analysis in chronic- and blast-phase myeloproliferative neoplasmsA Pardanani, T L Lasho, C M Finke, et al.Pageof 30